Page last updated: 2024-10-21

vanilmandelic acid and Bright Disease

vanilmandelic acid has been researched along with Bright Disease in 3 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iimura, O1
Kalmykova, IN1
Gitlow, SE1
Mendlowitz, M1
Bertani, LM1
Wilk, EK1
Glabman, S1

Other Studies

3 other studies available for vanilmandelic acid and Bright Disease

ArticleYear
Actual incidence of secondary hypertension.
    Japanese circulation journal, 1973, Volume: 37, Issue:9

    Topics: Adult; Aldosterone; Biopsy; Blood Pressure; Catecholamines; Cushing Syndrome; Diagnosis, Differentia

1973
[Diurnal periodicity of the adrenal function in diffuse glomerulonephritis in children].
    Pediatriia, 1969, Volume: 48, Issue:7

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Chromatography, Thin Layer; Circadian Rhythm; Glomerulone

1969
Tritium excretion of normotensive and hypertensive subjects after administration of tritiated norepinephrine.
    The Journal of laboratory and clinical medicine, 1969, Volume: 73, Issue:1

    Topics: Adult; Aged; Blood Pressure Determination; Catecholamines; Chromatography, Paper; Female; Glomerular

1969